Japan's AnGes biopharmaceutical company, which is developing a DNA vaccine against the novel coronavirus, has begun clinical trials in two groups of 30 volunteers, Ryuichi Morishita, the company's founder and a professor of clinical gene therapy at Osaka University, told Sputnik on Tuesday

Japan's AnGes biopharmaceutical company developing a DNA vaccine against the novel coronavirus is ready to cooperate with Russian companies both at the stage of scientific research and at the production stage, Ryuichi Morishita, the company's founder and a professor of clinical gene therapy at Osaka University, told Sputnik on Wednesday

The first human trials of a vaccine against COVID-19 produced by Japanese researchers will commence on June 30, Hirofumi Yoshimura, the governor of Osaka prefecture, said Wednesday